Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 08, 2024 16:07 ET | Source: Tevogen Bio Inc

Ryan Saadi Congratulates Marc Benioff on Receiving the Yale Legend in Leadership Award and Commends Yale School of Management for Recognizing the Importance of Integrating Corporate Success with Social Responsibility

WARREN, N.J., July 08, 2024 (GLOBE NEWSWIRE) -- Ryan Saadi, MD, MPH, founding CEO of Tevogen Bio (“Tevogen”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech pioneer developing...
April 26, 2024 09:23 ET | Source: Tevogen Bio Inc

Tevogen Bio CEO Highlights Expected Reporting of a $94.9 Million Liability Elimination, AI Initiative, and Leadership Appointments

Tevogen Bio CEO Highlights Expected Reporting of a $94.9 Million Liability Elimination, AI Initiative, and Leadership Appointments
December 13, 2022 04:00 ET | Source: IncludeHealth

IncludeHealth to Provide Musculoskeletal Care in Patients’ Homes in Partnership with Yale New Haven Health

CINCINNATI, OHIO, Dec. 13, 2022 (GLOBE NEWSWIRE) -- IncludeHealth, a digital musculoskeletal (MSK) health company, today announced a partnership with Yale New Haven Health System (YNHHS) to...
October 24, 2022 07:00 ET | Source: Algernon Pharmaceuticals

Algernon Pharmaceuticals Enters into a Clinical Trial Agreement with Yale University for a DMT Phase 2 Depression Study

VANCOUVER, British Columbia, Oct. 24, 2022 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF) a clinical stage pharmaceutical...
September 14, 2022 12:30 ET | Source: Burroughs Wellcome Fund

Researchers Investigate Nature’s Smallest “Social Cheaters”

Research Triangle Park, N.C., Sept. 14, 2022 (GLOBE NEWSWIRE) -- Being a member of a community often requires sacrifice. Species from across the animal kingdom have been shown to cooperate with...
June 21, 2022 09:00 ET | Source: Clearmind Medicine Inc.

Yale’s Department of Psychiatry Chair to Join Clearmind Medicine

Dr. John H. Krystal, world-leading expert in alcoholism and depression, will serve on scientific advisory board VANCOUVER, June 21, 2022 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (CSE: CMND,...
February 21, 2022 08:30 ET | Source: Blue Federal Credit Union

Blue Federal Credit Union Announces Grand Re-Opening of Denver Location

Denver, Colorado, Feb. 21, 2022 (GLOBE NEWSWIRE) -- Blue Federal Credit Union is excited to announce the grand re-opening of its south Denver branch located at 6460 East Yale Avenue. The opening...
February 08, 2022 07:30 ET | Source: Xanadu Bio

Xanadu Bio Obtains Licenses and Options to Novel Platform Technologies from Yale University to Develop an Intranasal SARS CoV-2 mRNA Vaccine Booster Aimed at Inducing Local Mucosal Immunity to Prevent SARS CoV-2 Infection and Virus Transmission

~ Company licenses PACE, a next generation polymeric nanoparticle delivery platform, and options intranasal PACE/Spike mRNA and Spike recombinant protein vaccine boosters for the treatment of...
December 14, 2020 08:00 ET | Source: Posit Science

Study: New Intervention Helps with Alcohol-related Cognitive Impairment

SAN FRANCISCO, Dec. 14, 2020 (GLOBE NEWSWIRE) -- Researchers at Yale published positive results from a pilot study of a novel combination therapy in patients with Mild Cognitive Impairment related...
August 03, 2020 07:00 ET | Source: Cybrexa Therapeutics

Cybrexa Therapeutics Expands Scientific Advisory Board With Appointment of Leader in Lung Cancer Research Roy Herbst, M.D., Ph.D.

NEW HAVEN, Conn., Aug. 03, 2020 (GLOBE NEWSWIRE) -- Cybrexa Therapeutics, an oncology-focused biotechnology company developing a new class of therapeutics through its alphalex™ tumor targeting...